Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19805,805,0.99 [0.91-1.08],0.8256969534403693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19184,235,0.96 [0.82-1.12],0.599491814318394
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21963,136,0.95 [0.78-1.16],0.6147373640753536
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14816,801,1.00 [0.91-1.09],0.9614898458083668
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21923,96,0.94 [0.74-1.19],0.6084623721274685
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19879,88,0.85 [0.66-1.10],0.2268283002313702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22949,95,0.95 [0.75-1.21],0.7036633461263819
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22961,65,0.88 [0.66-1.19],0.4092320268519803
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19467,53,1.14 [0.83-1.54],0.4177487226237339
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21980,115,0.87 [0.69-1.09],0.2160139460138547
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21947,82,0.76 [0.58-1.00],0.0531109896899992
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23034,57,1.11 [0.82-1.49],0.5084699068078966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23059,62,1.08 [0.82-1.44],0.5758489437385321
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23052,55,1.10 [0.81-1.49],0.5374966282233986
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,22724,42,1.02 [0.72-1.46],0.9073435047601828
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21806,386,1.01 [0.90-1.14],0.848701704884697
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21570,150,1.00 [0.83-1.21],0.9893396244267813
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21681,261,0.99 [0.86-1.14],0.8792164097202633
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",18025,79,1.05 [0.81-1.37],0.7100511024737819
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",17994,48,0.95 [0.67-1.33],0.7617497308497991
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18204,258,0.99 [0.85-1.15],0.894802630219544
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18213,267,1.00 [0.87-1.16],0.9906727060378868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18178,232,0.96 [0.82-1.12],0.6170329599241597
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",17999,53,1.01 [0.74-1.39],0.9430365684539108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20469,545,0.98 [0.89-1.09],0.7158761554574254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21578,368,0.99 [0.88-1.12],0.8983404521713073
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22467,123,0.89 [0.72-1.11],0.296327384178688
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23094,130,0.96 [0.78-1.18],0.7043836135831452
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,22770,73,1.02 [0.78-1.34],0.8843302867435335
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23110,64,1.15 [0.87-1.53],0.3321711071423392
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Stomach,23156,46,0.97 [0.69-1.38],0.8783506039781925
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,22839,309,0.97 [0.85-1.11],0.6384104312635
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23121,106,0.87 [0.69-1.10],0.2522090014856657
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23129,73,0.85 [0.64-1.13],0.2650965294439401
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23078,33,0.76 [0.49-1.16],0.204609812534993
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",23081,33,0.76 [0.49-1.16],0.2047754993784419
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,23007,127,1.19 [0.98-1.45],0.0826140748166605
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23135,53,1.40 [1.05-1.86],0.0229202476217065
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,23043,135,0.80 [0.65-0.99],0.04056587620702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21988,121,1.08 [0.88-1.33],0.4653544210839377
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21617,252,0.95 [0.82-1.10],0.4722274779083584
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21617,252,0.95 [0.82-1.10],0.4722274779083584
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19430,494,1.02 [0.92-1.13],0.710398368003619
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22652,38,0.70 [0.47-1.04],0.076948494376323
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22906,60,1.16 [0.87-1.54],0.3000798060502212
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18133,1411,0.97 [0.90-1.03],0.3271534911801259
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22452,178,1.08 [0.91-1.29],0.3564043853042351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20457,150,1.04 [0.86-1.25],0.7165259032814559
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21827,159,0.93 [0.77-1.12],0.4634710975124444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20442,135,0.98 [0.80-1.19],0.8176465050632289
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,20985,678,0.96 [0.87-1.06],0.3952848364168367
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,20960,653,0.95 [0.86-1.05],0.3424005434279027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21450,171,0.80 [0.64-0.98],0.0353594210921678
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21450,170,0.80 [0.65-0.99],0.0401067755169245
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17981,1259,0.95 [0.89-1.02],0.1931242619920976
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16903,181,0.92 [0.77-1.11],0.3942925500447293
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,17878,1156,0.96 [0.89-1.04],0.3267727345752147
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16771,49,1.30 [0.95-1.77],0.0961551504922294
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16820,98,0.86 [0.68-1.10],0.2430687522440984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,19637,667,1.07 [0.98-1.17],0.152853640118447
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19301,331,1.12 [0.98-1.28],0.0847554119650238
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22604,255,1.14 [0.99-1.31],0.0729073252675966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22691,195,1.23 [1.05-1.44],0.0090462686569337
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21104,76,0.95 [0.73-1.25],0.7281695546734053
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23015,76,0.94 [0.72-1.23],0.664091666561178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19046,76,0.95 [0.72-1.24],0.6953762151607632
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Alcohol dependence,21140,112,1.19 [0.96-1.47],0.1176963379841138
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,21131,80,1.21 [0.95-1.56],0.126567462402662
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19033,63,0.84 [0.62-1.14],0.257484827237732
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19232,262,1.10 [0.96-1.27],0.1755215172776443
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Depression,21998,222,1.11 [0.96-1.29],0.1573137199299781
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Depression or dysthymia,18943,189,1.13 [0.96-1.33],0.1566457291272062
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19071,101,0.92 [0.73-1.17],0.5046466970232675
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Other anxiety disorders,22182,53,0.82 [0.59-1.14],0.2377057711085531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,19613,1282,0.99 [0.93-1.06],0.8106898020334495
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17655,81,0.96 [0.74-1.25],0.7756497846687457
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23060,58,0.97 [0.72-1.31],0.8345877875505318
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21855,528,1.00 [0.91-1.11],0.9392881034146574
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,21484,157,0.84 [0.69-1.01],0.065960242391127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,21360,33,1.09 [0.74-1.61],0.6648996945256074
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22997,27,1.09 [0.71-1.67],0.7052590682011846
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22214,97,0.93 [0.73-1.18],0.5368001519116036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,21561,234,1.12 [0.96-1.30],0.1429493960891942
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,22443,184,1.09 [0.92-1.29],0.3423987062258333
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22241,463,1.01 [0.91-1.13],0.8161067188583447
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21895,117,1.08 [0.88-1.34],0.4473852006148342
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21994,216,0.95 [0.80-1.11],0.4985037095186679
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22819,86,0.98 [0.76-1.25],0.8447855947009174
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,22788,55,1.11 [0.82-1.50],0.5080602034813241
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,22664,114,0.88 [0.70-1.10],0.2582456839792612
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22580,300,0.97 [0.85-1.11],0.6675747378981747
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22451,171,0.98 [0.82-1.17],0.7940571935890939
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22355,75,0.96 [0.73-1.26],0.7604677542785062
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22384,104,0.96 [0.77-1.22],0.761451655726679
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22328,48,1.10 [0.79-1.53],0.5730025880714398
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20233,138,1.08 [0.89-1.32],0.4279204031349267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20471,376,1.01 [0.89-1.14],0.9129663266870904
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22203,246,1.20 [1.04-1.38],0.0139226334486262
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22759,71,1.36 [1.05-1.77],0.0180240052597961
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2519,71,1.35 [1.04-1.76],0.0240456993218949
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20311,71,1.34 [1.04-1.74],0.0254788616143416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22514,93,0.82 [0.64-1.06],0.1307321931193824
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22470,49,0.92 [0.66-1.29],0.6329599812278562
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22618,75,0.93 [0.71-1.23],0.6226336279869149
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22641,90,0.81 [0.63-1.05],0.1073337922716849
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23068,133,1.13 [0.93-1.37],0.2265281743639401
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22244,98,0.98 [0.77-1.23],0.8419984111975913
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15647,3671,0.91 [0.86-0.95],0.0001513183323416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22479,61,0.69 [0.50-0.95],0.0228933098030923
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16512,2407,0.94 [0.89-1.00],0.0448621310434408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,16557,2452,0.95 [0.90-1.00],0.0667887890146878
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14213,108,0.89 [0.70-1.12],0.3187213571969169
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20494,1637,0.88 [0.83-0.94],9.095326179268804e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,19774,917,0.87 [0.80-0.95],0.0013392114679176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21750,327,1.03 [0.91-1.17],0.6372744548988791
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22136,713,0.95 [0.87-1.04],0.3042045562032427
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22961,158,0.88 [0.73-1.07],0.2082035075579296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19342,485,0.89 [0.80-0.99],0.03969476237329
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20230,1396,0.90 [0.84-0.96],0.0015657043256946
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22304,117,0.91 [0.73-1.14],0.4154343217251227
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22406,237,0.93 [0.80-1.08],0.3492654049170363
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22270,83,1.03 [0.80-1.32],0.8347646895145828
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22272,85,1.04 [0.81-1.33],0.7647172577597159
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14184,79,1.04 [0.80-1.35],0.7883184867641502
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18116,78,1.02 [0.78-1.33],0.9045008644766968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,18201,163,0.85 [0.70-1.03],0.1009204552741759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11455,131,0.76 [0.61-0.95],0.015707303142255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11911,587,0.81 [0.72-0.90],0.0001249013692695
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,18120,82,0.98 [0.76-1.27],0.8872755605352693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18161,123,0.69 [0.55-0.87],0.0017458604055492
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21883,306,0.92 [0.80-1.05],0.2283482290536914
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22149,181,1.08 [0.91-1.28],0.3778631730298906
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22175,164,1.11 [0.93-1.33],0.2482995497830863
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22262,145,1.14 [0.95-1.38],0.1633964146782281
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21797,84,0.79 [0.61-1.03],0.084300995369208
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21854,141,1.00 [0.82-1.21],0.973288453893186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21862,148,0.99 [0.81-1.19],0.8891457469747951
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21846,132,0.96 [0.78-1.18],0.6985596069485733
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22927,125,0.99 [0.80-1.22],0.9378891054827864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,22041,327,0.84 [0.74-0.96],0.0122707182338104
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,21904,81,0.93 [0.71-1.21],0.5948381763443248
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18049,1950,1.01 [0.96-1.07],0.7214819083274616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22988,86,1.22 [0.96-1.54],0.0996325424605503
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21092,245,1.04 [0.89-1.20],0.6459294052447369
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21055,208,1.02 [0.87-1.20],0.7642928816410397
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22214,269,0.91 [0.78-1.05],0.1867542213914985
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22211,266,0.90 [0.78-1.04],0.1498806940242716
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22330,640,1.01 [0.93-1.11],0.7569673397728415
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,21761,71,0.85 [0.64-1.13],0.2546027894541069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,21857,167,1.12 [0.94-1.33],0.2158252251049727
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22105,415,1.03 [0.92-1.15],0.6611404367289344
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,21909,219,1.02 [0.87-1.19],0.790585423865231
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10041,60,0.98 [0.72-1.33],0.8764135820942069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20699,820,1.04 [0.96-1.13],0.3390354633243806
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,21879,190,0.99 [0.84-1.18],0.9469093780459016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21909,220,1.06 [0.90-1.24],0.4885006039692297
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21909,220,1.06 [0.90-1.24],0.4885006039692297
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21787,638,1.04 [0.95-1.14],0.4447628625710406
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Asthma,15740,638,1.05 [0.95-1.15],0.3225778428325233
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15404,638,1.04 [0.95-1.14],0.3859498263737649
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15730,628,1.05 [0.95-1.15],0.3281780774889187
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22742,95,0.90 [0.70-1.14],0.3811071238186438
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,22021,75,0.91 [0.70-1.20],0.5216742795602876
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22823,75,0.91 [0.70-1.20],0.5219705658942536
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22014,68,0.86 [0.65-1.16],0.3251266487475899
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,20908,131,0.88 [0.71-1.08],0.2203253042177138
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,21052,275,0.98 [0.85-1.13],0.7414342200079636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21822,122,1.19 [0.97-1.45],0.0960288131815023
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15423,5445,0.98 [0.94-1.02],0.4255111709566516
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22683,352,1.00 [0.89-1.13],0.9779504449069352
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23127,76,1.01 [0.78-1.32],0.9220449873066504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,23130,73,1.00 [0.76-1.31],0.9919456402404075
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,22439,108,1.16 [0.94-1.44],0.1731835295939453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22410,79,0.94 [0.72-1.22],0.6181223488165966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23118,84,1.03 [0.80-1.33],0.801987410311128
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22408,77,0.90 [0.69-1.18],0.4499248543246332
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22183,75,1.17 [0.91-1.52],0.2177721522818522
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23062,54,1.08 [0.79-1.46],0.6383822830470656
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17726,313,1.05 [0.92-1.19],0.4923331088680389
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19361,1948,0.97 [0.92-1.02],0.2603456858136345
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,17798,385,1.03 [0.91-1.16],0.6734079171584533
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18040,627,0.93 [0.85-1.03],0.1570534101646583
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17483,70,0.88 [0.66-1.17],0.3892535383061299
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17679,266,0.96 [0.83-1.11],0.5633157148078728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17487,74,1.25 [0.97-1.61],0.0887539176970133
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,17568,155,0.95 [0.79-1.15],0.6017536902855658
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,17578,165,1.15 [0.97-1.37],0.1113000361712196
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22968,113,1.19 [0.97-1.46],0.0999546652644606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,17527,114,0.91 [0.73-1.14],0.400902427307522
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18182,769,0.99 [0.91-1.08],0.8396370527822732
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,23005,101,1.05 [0.83-1.31],0.7000577022863073
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,17696,283,0.97 [0.84-1.12],0.6693510584382178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17569,156,0.95 [0.78-1.14],0.5696577123901203
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22960,164,0.84 [0.69-1.01],0.0602840228128682
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,22987,83,1.05 [0.82-1.35],0.706121335184592
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,19748,1988,1.01 [0.96-1.07],0.7130769430854677
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,18853,1093,1.00 [0.93-1.08],0.961420069153998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,17936,176,0.87 [0.73-1.04],0.1357523062206035
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,17853,93,1.10 [0.87-1.40],0.4071588183501593
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18503,743,1.05 [0.96-1.14],0.3192302715166012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22317,582,1.02 [0.93-1.13],0.6267570264688547
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,17863,1762,0.94 [0.89-1.00],0.0475066118908955
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22828,53,1.14 [0.84-1.55],0.3894788646692796
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23085,69,1.18 [0.91-1.54],0.2116304484447962
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,21804,69,1.18 [0.91-1.54],0.2102331672880464
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21789,54,1.13 [0.84-1.52],0.4279523063795701
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23030,140,0.88 [0.72-1.08],0.2148800329439686
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,21875,140,0.88 [0.72-1.08],0.217723086278804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21861,126,0.92 [0.75-1.14],0.4559319033987759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22172,437,1.03 [0.93-1.15],0.5547935917055078
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22169,434,1.04 [0.93-1.16],0.5364829020233437
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16189,88,1.14 [0.89-1.45],0.2906364474826298
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal stricture,22708,88,1.16 [0.92-1.47],0.2173944510038802
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16162,61,1.13 [0.85-1.51],0.3984255527101122
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16619,518,0.93 [0.84-1.04],0.1998799855569575
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16186,85,0.95 [0.74-1.23],0.7204752048194221
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16275,174,0.97 [0.81-1.16],0.7075215664060175
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,21627,158,0.96 [0.79-1.15],0.646154692037239
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22779,50,1.25 [0.92-1.70],0.1585919796289623
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16257,156,0.82 [0.68-1.00],0.046336506439528
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16194,93,0.97 [0.77-1.24],0.834344452315119
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16946,845,0.95 [0.88-1.04],0.2580831112662352
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,16404,303,0.98 [0.86-1.13],0.7877961354136757
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22769,40,1.30 [0.92-1.83],0.1317093781423063
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,22340,137,0.77 [0.63-0.95],0.0160819752050999
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,22284,81,0.74 [0.56-0.97],0.0284381910124028
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22046,361,1.02 [0.91-1.16],0.6941085834685039
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,21949,264,1.06 [0.92-1.22],0.4047900217569991
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,21749,64,0.99 [0.74-1.33],0.9567458929937768
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21718,33,1.22 [0.83-1.79],0.3035750854727718
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,21754,69,1.04 [0.79-1.37],0.7717412641598866
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),22972,69,1.04 [0.79-1.37],0.7917184870678952
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21799,306,0.99 [0.87-1.13],0.9004879870175728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21528,35,1.00 [0.67-1.47],0.985677935333253
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,21519,26,1.03 [0.66-1.62],0.8874058003143731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21551,58,1.03 [0.76-1.40],0.8494066026786733
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21712,219,0.98 [0.84-1.15],0.8037310707782312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,21708,215,0.97 [0.83-1.14],0.716329320405735
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20076,1454,0.95 [0.89-1.01],0.0971453149592691
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22712,91,1.04 [0.82-1.32],0.7699515457577436
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22775,439,0.90 [0.81-1.01],0.0764186402171846
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21577,446,0.94 [0.84-1.05],0.2435826677249671
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22176,460,0.97 [0.87-1.08],0.5954087931882243
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21822,106,0.90 [0.72-1.13],0.3754529025189155
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22013,297,1.02 [0.89-1.16],0.8009996262973577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22883,88,0.89 [0.69-1.14],0.3575959143057852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22869,74,0.93 [0.71-1.23],0.6154542529282967
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22849,54,0.97 [0.70-1.33],0.83610584090001
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22836,57,nan [nan-nan],
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22834,55,nan [nan-nan],
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22390,54,0.88 [0.64-1.22],0.4453576217555449
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22693,357,0.88 [0.78-1.00],0.0480109722363951
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21209,78,0.88 [0.67-1.16],0.3673491180210414
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21176,45,0.72 [0.50-1.04],0.081551523366425
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21171,40,0.75 [0.51-1.11],0.1502664984112662
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21309,178,1.05 [0.88-1.25],0.573690081141361
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21287,156,1.03 [0.86-1.25],0.7173639664423292
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17088,3461,1.02 [0.98-1.07],0.2880167806876907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18536,2036,1.01 [0.95-1.06],0.8252219778312581
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20953,1054,1.05 [0.98-1.13],0.155022096520461
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16588,88,1.17 [0.92-1.49],0.1977953137610257
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16895,395,0.97 [0.85-1.09],0.5716161602453067
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22899,85,1.15 [0.90-1.47],0.2524994448720379
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22903,75,1.27 [0.99-1.63],0.0607072280904036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17538,1038,1.01 [0.93-1.09],0.8375757040486604
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19903,1038,1.00 [0.93-1.08],0.9562665934285398
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16622,122,1.04 [0.84-1.29],0.72870172489758
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22223,118,0.99 [0.80-1.24],0.95759729420651
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16657,157,0.81 [0.66-0.98],0.0314341108619021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16554,54,0.89 [0.64-1.23],0.4737366938139136
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16745,245,0.93 [0.80-1.08],0.3551609497405835
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23026,117,0.94 [0.75-1.17],0.591014234062138
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17060,560,1.02 [0.92-1.13],0.6690869151670902
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16796,296,0.97 [0.84-1.11],0.6417921269426962
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17624,1124,1.00 [0.93-1.07],0.9365185464357856
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16523,23,0.62 [0.36-1.06],0.0788762902969078
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16545,45,1.04 [0.73-1.47],0.8348820759999884
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16529,29,1.28 [0.85-1.93],0.228942580801888
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16514,14,0.76 [0.39-1.47],0.4104098403207162
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17081,581,1.03 [0.93-1.13],0.5623602936468128
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17007,507,1.04 [0.94-1.15],0.4674420479808235
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18691,252,0.86 [0.74-1.01],0.0611172809584779
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22865,35,1.04 [0.71-1.53],0.8263309559842146
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22847,17,1.00 [0.57-1.75],0.9987145936433692
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20242,44,0.81 [0.56-1.17],0.2549074372898442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20469,271,0.92 [0.80-1.07],0.2792008692172141
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20994,796,0.97 [0.90-1.06],0.5457441315394967
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20351,153,0.95 [0.79-1.15],0.6096147779759842
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20288,90,0.87 [0.68-1.12],0.2880313266058255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20818,620,0.99 [0.90-1.09],0.8751781477258074
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20247,49,1.22 [0.89-1.67],0.2221538359165947
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20416,218,1.06 [0.90-1.23],0.4954127002859748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20292,94,1.10 [0.87-1.39],0.4158409375974166
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20260,62,0.86 [0.63-1.17],0.3282541982123609
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20311,113,0.99 [0.80-1.24],0.939238492110693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20247,49,0.95 [0.68-1.32],0.7519297463943383
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20447,249,0.95 [0.82-1.11],0.5169139072983526
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20133,234,1.05 [0.90-1.22],0.5235814188310559
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19962,63,1.07 [0.80-1.43],0.6284699407019254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19961,62,1.10 [0.83-1.47],0.511610576127256
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19959,60,0.99 [0.74-1.34],0.9635164284144152
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19959,60,1.17 [0.88-1.56],0.2806432358228208
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20068,169,1.15 [0.96-1.37],0.1192716893737112
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20057,158,1.13 [0.94-1.36],0.1798869121946839
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20142,243,1.06 [0.91-1.23],0.4335410529596601
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19947,48,1.00 [0.71-1.40],0.9944311838743926
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19985,86,1.11 [0.87-1.42],0.4106217204077097
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20009,110,1.04 [0.83-1.30],0.7278736729574409
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19941,42,0.79 [0.54-1.15],0.2145575429692799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20239,340,0.99 [0.87-1.13],0.8964094086589185
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20042,143,1.07 [0.88-1.30],0.4910241012990937
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20079,180,0.99 [0.84-1.18],0.9463444062694348
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22149,101,1.11 [0.89-1.39],0.3585970356827096
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22334,286,1.06 [0.93-1.22],0.3610074798007557
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22105,57,1.04 [0.77-1.41],0.7772711667203276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22098,50,1.05 [0.76-1.45],0.7789991700469345
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22134,86,1.02 [0.80-1.31],0.8749653122675353
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17739,2315,1.00 [0.94-1.05],0.880573165189302
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19935,1257,1.01 [0.94-1.08],0.8175611930304825
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20426,304,0.97 [0.85-1.11],0.6560190678209377
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20214,92,0.87 [0.67-1.12],0.2756285608001509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20452,72,1.01 [0.77-1.32],0.9593101279218896
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20471,91,0.97 [0.76-1.24],0.8002433684133254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20473,93,0.84 [0.65-1.08],0.1683087355857335
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22674,350,0.99 [0.88-1.12],0.897216322814246
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22627,76,1.13 [0.87-1.47],0.347903587928753
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22571,247,1.03 [0.89-1.20],0.6720405229988637
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22456,132,0.97 [0.79-1.19],0.7799451582049659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,20975,805,1.00 [0.92-1.09],0.9932173604825004
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,20223,53,0.89 [0.64-1.24],0.483735214675403
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20242,72,1.06 [0.81-1.40],0.6485032354456679
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20539,369,1.00 [0.88-1.13],0.9621459196123764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20306,136,0.98 [0.80-1.20],0.8771000946794646
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20523,353,0.99 [0.88-1.13],0.917580739903479
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19231,553,1.04 [0.94-1.15],0.4434937609390108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18782,104,1.05 [0.84-1.32],0.6572246986825026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydrocele,18777,99,0.95 [0.75-1.20],0.643806013152987
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18842,164,1.06 [0.89-1.27],0.5197581333278742
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18839,161,1.13 [0.94-1.35],0.183665123851366
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18891,213,0.88 [0.75-1.04],0.1405876738481529
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22650,76,0.93 [0.71-1.22],0.5928201238256223
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21010,531,1.00 [0.91-1.11],0.9342803835209966
